Skip to main content
. 2021 Oct 28;17(1):e202100576. doi: 10.1002/cmdc.202100576

Table 1.

Summary of SARS coronavirus 3CLpro inhibitor patents in chronological order up to 30 July 2021.

Patent number

Applicant/Assignee

Filing date (dd.mm.yyyy)

Inhibitor type

Fig.

Ref.

WO 2004/093860

Pfizer

13.04.2004

peptidomimetic

1

[20]

WO 2004/101742

Cytovia

06.05.2004

peptidomimetic

2

[21]

US 2006/0014821

Agouron Pharmaceuticals

13.08.2004

peptidomimetic

3

[22]

WO 2005/041904

Fulcrum Pharmaceuticals

01.11.2004

small molecule

4

[23]

WO 2005/066123

Taigen Biotechnology

28.12.2004

peptidomimetic

5

[24]

WO 2005/113580

Pfizer

09.05.2005

peptidomimetic

6

[25]

US 2006/0019967

National Health Research Institutes, Taiwan

20.07.2005

small molecule

7

[26]

WO 2006/042478

Tsinghua University, Shanghai Institute of Organic Chemistry

24.10.2005

peptidomimetic

8

[27]

CN 1965833 A

Peking University

18.11.2005

small molecule

9

[28]

WO 2006/061714

Pfizer

06.12.2005

peptidomimetic

10

[29]

WO 2006/095624

Tokyo Medical and Dental University, RIKEN

01.03.2006

small molecule

11

[30]

WO 2007/075145

Singapore Polytechnic, Shanghai Institute of Materia Medica

15.12.2006

small molecule

12

[31]

CN 103159665B

Tianjin International Joint Academy of Biotechnology and Medicine

09.12.2011

small molecule

13

[32]

WO 2013/049382

Kansas State University, Ohio State University, Wichita State University

27.09.2012

peptidomimetic

14

[33]

KR 1020130002975

Chonnam National University

20.12.2012

small molecule

15

[34]

WO 2013/166319

Kansas State University, Wichita State University

02.05.2013

peptidomimetic

16

[35]

CN 106176728 A

Institute of Microbiology, Chinese Academy of Sciences

07.07.2016

small molecule

17

[36]

WO 2017/114509

Shanghai Institute of Materia Medica, University of Lübeck

30.12.2016

peptidomimetic

18

[37]

US 2017/0313685

Purdue Research Foundation

28.04.2017

small molecule

19

[38]

WO 2017/222935

Kansas State University, Wichita State University

16.07.2017

peptidomimetic

20

[39]

CN 108785293 A

Tianjin International Joint Academy of Biomedicine

28.04.2017

small molecule

21

[40]

WO 2018/042343

GSK

30.08.2017

peptidomimetic

22

[41]

WO 2020/030143

Shanghai Institute of Materia Medica, Fudan University

09.08.2019

peptidomimetic

23

[42]

WO 2021/176369

Pfizer

03.03.2021

peptidomimetic

24

[43]